Outcome of 5-Azacitidine and Decitabine Treatment in Elderly Patients with Myelodysplastic Syndrome

被引：0
|
作者：
Nam, Seung-Hyun [1 ]
Lim, Taekyu [1 ]
Kim, Bong-Seog [1 ]
机构：
[1] VHS Med Ctr, Seoul, South Korea
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4959.4959
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4959
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Azacitidine for the treatment of myelodysplastic syndrome
    Cataldo, Vince D.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 875 - 884
  • [42] Allogeneic hematopoietic cell transplantation (HCT) for myelodysplastic syndrome (MDS) after pretransplant 5-azacitidine
    Field, Teresa
    Alsina, Melissa
    Ayala, Ernesto
    Fernandez, Hugo
    Janssen, William
    Karfan-Dabaja, Mohammed
    Lancer, Jeffery
    Melchert, Mafda
    Raychaudhuri, Jyoti
    Sullivan, Daniel
    List, Alan
    Anasetti, Claudio
    Poling, William
    Perkins, Janelle
    BLOOD, 2007, 110 (11) : 338B - 338B
  • [43] A pilot trial of anti-KIR antibody with or without 5-azacitidine for myelodysplastic syndrome.
    Yalniz, Fevzi Firat
    Daver, Naval Guastad
    Kornblau, Steven Mitchell
    Ohanian, Maro
    Borthakur, Gautam
    Dinardo, Courtney Denton
    Konopleva, Marina
    Burger, Jan Andreas
    Gasior, Yvonne
    Pierce, Sherry
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes
    Lee, Yun-Gyoo
    Kim, Inho
    Yoon, Sung-Soo
    Park, Seonyang
    Cheong, June Won
    Min, Yoo Hong
    Lee, Jeong-Ok
    Bang, Soo-Mee
    Yi, Hyeon Gyu
    Kim, Chul Soo
    Park, Yong
    Kim, Byung-Soo
    Mun, Yeung-Chul
    Seong, Chu-Myoung
    Park, Jinny
    Lee, Jae Hoon
    Kim, Sung-Yong
    Lee, Hong Ghi
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 339 - 347
  • [45] Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome
    Je-Hwan Lee
    Yunsuk Choi
    Sung-Doo Kim
    Dae-Young Kim
    Jung-Hee Lee
    Kyoo-Hyung Lee
    Sang-Min Lee
    Su-Hee Cho
    Won-Sik Lee
    Young-Don Joo
    Annals of Hematology, 2013, 92 : 889 - 897
  • [46] Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome
    Lee, Je-Hwan
    Choi, Yunsuk
    Kim, Sung-Doo
    Kim, Dae-Young
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Lee, Sang-Min
    Cho, Su-Hee
    Lee, Won-Sik
    Joo, Young-Don
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 889 - 897
  • [47] A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome
    Almasri, Jehad
    Alkhateeb, Hassan B.
    Firwana, Belal
    Sonbol, Mohamad Bassam
    Damlaj, Moussab
    Wang, Zhen
    Murad, M. Hassan
    Al-Kali, Aref
    SYSTEMATIC REVIEWS, 2018, 7
  • [48] Comparison Between Decitabine and Azacitidine for the Treatment of Myelodysplastic Syndrome: A Meta-Analysis With 1392 Participants
    Xie, Mixue
    Jiang, Qi
    Xie, Yanhui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (01): : 22 - 28
  • [49] A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome
    Jehad Almasri
    Hassan B. Alkhateeb
    Belal Firwana
    Mohamad Bassam Sonbol
    Moussab Damlaj
    Zhen Wang
    M. Hassan Murad
    Aref Al-Kali
    Systematic Reviews, 7
  • [50] COMPASIVE USE OF 5-AZACITIDINE IN PATIENTS WITH LOW/INT-1 RISK MYELODYSPLASTIC SYNDROMES
    de Miguel, D.
    Golbano, N.
    San Roman, I.
    Arbeteta, J.
    Diaz, M.
    Morales, D.
    Herrero, S.
    Subira, D.
    PInedo, B.
    HAEMATOLOGICA, 2012, 97 : 581 - 581
12345